Preclinical evidence for the use of <scp>anti‐Trop</scp> ‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer
Richard Weiten(University Hospital Bonn), Niklas Klümper(University of Bonn)
Cited by 9
Related Papers
AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer
|Nature Communications|2024|18